Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy

Despite the significant progress of modern anticancer therapies, multiple myeloma (MM) is still incurable for the majority of patients. Following almost three decades of development, chimeric antigen receptor (CAR) T-cell therapy now has the opportunity to revolutionize the treatment landscape and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Grywalska, Ewelina, Sosnowska-Pasiarska, Barbara, Smok-Kalwat, Jolanta, Pasiarski, Marcin, Niedźwiedzka-Rystwej, Paulina, Roliński, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226998/
https://www.ncbi.nlm.nih.gov/pubmed/32316105
http://dx.doi.org/10.3390/cells9040983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226998/
https://www.ncbi.nlm.nih.gov/pubmed/32316105
http://dx.doi.org/10.3390/cells9040983

Ejemplares similares